These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 31268164)
1. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data. Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164 [TBL] [Abstract][Full Text] [Related]
2. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma. Wu F; Chen Q; Liu C; Duan X; Hu J; Liu J; Cao H; Li W; Li H Cancer Med; 2020 Mar; 9(6):2171-2180. PubMed ID: 31975560 [TBL] [Abstract][Full Text] [Related]
3. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma. Zhang D; Duan Y; Wang Z; Lin J Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577 [TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma. Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826 [TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma. Liu Z; Ye J; Khan AA; Chen J; Zhou L; Zheng S; Xu X Med Sci Monit; 2021 Aug; 27():e930052. PubMed ID: 34407065 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases. He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
9. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma. Xing L; Zhang X; Tong D DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877 [TBL] [Abstract][Full Text] [Related]
10. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
11. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma. Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma. Han Q; Wang X; Liao X; Han C; Yu T; Yang C; Li G; Han B; Huang K; Zhu G; Liu Z; Zhou X; Su H; Shang L; Gong Y; Song X; Peng T; Ye X Oncol Rep; 2019 Sep; 42(3):895-910. PubMed ID: 31322232 [TBL] [Abstract][Full Text] [Related]
13. Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein. Jin YJ; Aycheh HM; Han S; Chamberlin J; Shin J; Byun S; Lee Y BMC Med Genomics; 2020 Dec; 13(Suppl 11):194. PubMed ID: 33371894 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma. Duan Y; Zhang D J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370 [TBL] [Abstract][Full Text] [Related]
15. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma. Wan Q; Sang X; Jin L; Wang Z Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099 [TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma. Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816 [TBL] [Abstract][Full Text] [Related]
17. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data. Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810 [TBL] [Abstract][Full Text] [Related]
18. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663 [TBL] [Abstract][Full Text] [Related]
19. A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma. Lin Z; Cai YJ; Chen RC; Chen BC; Zhao L; Xu SH; Wang XD; Song M; Wu JM; Wang YQ; Zhou MT; Shi KQ Clin Chim Acta; 2017 Jun; 469():171-179. PubMed ID: 28365450 [TBL] [Abstract][Full Text] [Related]
20. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas. Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]